1. Home
  2. OGN vs PRGO Comparison

OGN vs PRGO Comparison

Compare OGN & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.38

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Perrigo Company plc

PRGO

Perrigo Company plc

HOLD

Current Price

$11.08

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGN
PRGO
Founded
1923
1887
Country
United States
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
OGN
PRGO
Price
$13.38
$11.08
Analyst Decision
Hold
Buy
Analyst Count
5
3
Target Price
$11.40
$19.33
AVG Volume (30 Days)
5.0M
2.4M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
0.60%
10.28%
EPS Growth
N/A
N/A
EPS
0.55
N/A
Revenue
$6,216,000,000.00
$800,000.00
Revenue This Year
$0.45
N/A
Revenue Next Year
$1.67
$1.02
P/E Ratio
$24.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.69
$9.23
52 Week High
$13.48
$28.44

Technical Indicators

Market Signals
Indicator
OGN
PRGO
Relative Strength Index (RSI) 74.68 48.03
Support Level $10.05 $10.46
Resistance Level $13.46 $12.36
Average True Range (ATR) 0.05 0.47
MACD -0.22 0.01
Stochastic Oscillator 47.50 40.14

Price Performance

Historical Comparison
OGN
PRGO

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Share on Social Networks: